1. Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis. Issue 8 (6th May 2019) Authors: Poordad, Fred; Sedghi, Shahriar; Pockros, Paul J.; Ravendhran, Natarajan; Reindollar, Robert; Lucey, Michael R.; Epstein, Michael; Bank, Leslie; Bernstein, David; Trinh, Roger; Krishnan, Preethi; Polepally, Akshanth R.; Unnebrink, Kristina; Martinez, Marisol; Nelson, David R. Journal: Journal of viral hepatitis Issue: Volume 26:Issue 8(2019) Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019) Authors: Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019) Authors: Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Issue 7 (4th August 2015) Authors: Zeuzem, S.; Flisiak, R.; Vierling, J. M.; Mazur, W.; Mazzella, G.; Thongsawat, S.; Abdurakhmanov, D.; Van Kính, N.; Calistru, P.; Heo, J.; Stanciu, C.; Gould, M.; Makara, M.; Hsu, S.‐J.; Buggisch, P.; Samuel, D.; Mutimer, D.; Nault, B.; Merz, M.; Bao, W. Journal: Alimentary pharmacology & therapeutics Issue: Volume 42:Issue 7(2015) Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study. (26th December 2016) Authors: Alam, Imtiaz; Brown, Kimberley; Donovan, Cynthia; Forlenza, Jamie; Lauwers, Kris; Mah'moud, Mitchell A.; Manch, Richard; Mohanty, Smruti R.; Prabhakar, Avinash; Reindollar, Robert; DeMasi, Ralph; Slim, Jihad; Tandon, Neeta; Villadiego, Shirley; Naggie, Susanna Journal: Open forum infectious diseases Issue: Volume 4:Number 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sustained Virologic Response Predicts Fibrosis Regression Measured by FibroTest in HCV‐infected Patients: 828. (October 2016) Authors: Forns, Xavier; Welzel, Tania M.; Cohen, Eric; Jacobson, Ira M.; Davis, Mitchell; Reindollar, Robert; Hu, Bonnie; Dylla, Douglas E.; Enejosa, Jeffrey V.; Trinh, Roger; Sulkowski, Mark S. Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗